A Smart + Strong Site
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Post-Conference Report Provides HIV Cure Roadmap
Life Expectancy With HIV Increases Dramatically
Improper Use of a Neti Pot Can Be Fatal
Animal Studies Suggest Anti-Reservoir Drugs May Help 'Functionally Cure' HIV
Tenofovir Microbicide Gel Falters in Major HIV Prevention Study
Gold Drug Shows HIV Eradication Potential
New Studies Under Way of Sangamo's Possible 'Functional Cure' Gene Therapy
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailrssprint

February 6, 2006

Investigating Reports of Excessive False-Positive Oral Fluid Rapid HIV Tests

by Tim Horn

Over the past several months, there have been numerous mainstream media reports regarding an unusually high number of false-positive HIV-antibody test results using the oral-based OraQuick rapid assay (the reliability of the blood-based OraQuick assay hasn't been disputed). Dr. Bernard Branson and his colleagues at the U.S. Centers for Disease Control have investigated these reports and reported their findings at the 13th Conference on Retroviruses and Opportunistic Infections in Denver.

Dr. Branson's group looked at three testing sites in New York City that have reported excessive false-positives (cases), along with seven sites in the city that have not reported excessive false-positives (controls). And in San Francisco, his group looked at one site with excessive false-positive and 11 sites without excessive false-positive test results.

Using November 2005 as an example, 1581 individuals were tested throughout the month at one of the three case clinics in New York City. There were 32 false-positive rates in total, yielding a testing specificity of 98%. Among the seven control testing sites, 2164 people were tested in November. There were three false-positive test results, putting the specificity at 99.9%. In San Francisco during the same month, 160 oral-based tests were conducted at the case clinic, six of which turned out to be false-positive (yielding a specificity of 96.3%). In the 11 control clinics, 551 tests were conducted, with five false-positive test results (yielding a specificity of 99.1%).

The FDA minimum threshold for specificity is 98%. Dr. Branson's group concluded that the false-positive results are not likely a limitation of the oral-based test themselves, but rather attributed to site-specific factors, including the possibility of procedural errors. The CDC is still looking into the discrepancies.

Source: Branson B, Wesolowski L, Delaney K. et al. Investigation of reports of excessive false-positive oral fluid rapid HIV tests [Abstract 34LBb]. 13th Conference on Retroviruses and Opportunistic Infections, Denver, 2006.

emailrssprint


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine


    AloneInNYC
    New york city
    New York


    JoeYorker
    New York
    New York


    jonjonhg
    nyc
    New York


    flowrider
    Dallas
    Texas
Click here to join POZ Personals!
Conference Coverage

6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011)
Rome, Italy
July 17 - 20, 2011


18th Conference on Retroviruses and Opportunistic Infections (CROI 2011)
Boston, MA
February 27 - March 2, 2011


XVIII International AIDS Conference
Vienna, Austria
July 18-23, 2010

more conference coverage


[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.